Associate Professor of Medicine
Dana-Farber Cancer Institute
Dr. Castillo was born in Peru, received his medical degree at the Universidad Autonoma Metropolitana in Mexico City, and completed Internal Medicine, and Hematology & Oncology training at the University of Massachusetts and Brown University, respectively. Dr. Castillo is an Associate Professor at Harvard Medical School, Senior Physician at the Dana-Farber Cancer Institute, and Clinical Director of the Bing Center for Waldenström Macroglobulinemia. Dr. Castillo is the principal investigator in innovative clinical trials evaluating highly effective non-chemotherapeutic approaches for patients with Waldenström macroglobulinemia. Dr. Castillo is a member of the Myeloma, Amyloidosis, and Waldenström Macroglobulinemia Committee at the National Comprehensive Cancer Network, and a member of the Scientific Advisory Committee of the International Waldenström Macroglobulinemia Foundation. He has authored over 300 peer-reviewed articles and has published his research in the New England Journal of Medicine, Lancet Oncology, Journal of Clinical Oncology, and Blood. Dr. Castillo has been awarded the Innovation Award by the Dana-Farber Cancer Institute, and the Robert A. Kyle Award by the International Workshop for Waldenström Macroglobulinemia.